Stay updated on Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.

Latest updates to the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAccess to the study record now displays a 403 Forbidden error page, replacing the previous study content. The new screen shows a standard site footer and navigation but no trial details, indicating access is blocked.SummaryDifference19%

- Check51 days agoChange DetectedRevision: v3.6.6 has been added on the page, replacing the previous Revision: v3.6.5.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision bumped to v3.6.5, indicating a minor system/template update with no changes to the study details or data.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now reports Revision: v3.6.4, replacing v3.6.3, indicating a maintenance update to the study record page. This update appears to be administrative and does not alter the study information presented.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.